News

Researchers at the UT Southwestern Medical Center have discovered a molecule that activates genes involved in the development and reproduction of caenorhabditis elegans (C elegans), a common research

This new approval also marks the eighth indication Remicade has received in Europe for the treatment of immune-mediated inflammatory disorders. The approval is specifically for patients who have

Current FDA-approved pharmaceutical-based osteoporosis treatments, such as bisphosphonate drugs and hormone therapies, do not effectively repair bone that has already been lost. In fact, bisphosphonates have been shown

The study sheds light on how nisin is made in nature and moves researchers closer to producing new antibiotics that would preclude the development and spread of antibiotic-resistant

UMN Pharma will use the PERC6 cell line in its UMN-03 project, which aims to employ a fusion protein in the treatment of muscular dystrophy and metabolic diseases

Obesity is due to a mismatch between the number of calories consumed and the amount of physical activity undertaken. In the brain, a region called the hypothalamus controls

All 12 members of the panel recommended that Tysabri should be re-launched with warnings about the safety concerns associated with the drug. The drug was pulled from the

The lawsuit is in response to an abbreviated new drug application filed by Ivax with the FDA for a generic version of the drug in the US prior

The third and final pre-market approval (PMA) module contains nine-month data from the ATLAS clinical trial, a global, multi-center, pivotal study designed to support FDA approval of the